The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase III randomized clinical trial evaluating perioperative therapy (neoadjuvant chemotherapy versus chemoradiotherapy) in locally advanced gallbladder cancers (POLCAGB).
 
Reena Engineer
No Relationships to Disclose
 
Mahesh Goel
No Relationships to Disclose
 
Vikas Ostwal
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); BDR Pharmaceutics (Inst); Cadila Pharmaceuticals (Inst); Dr. Reddy's Laboratories (Inst); Intas (Inst); Lupin Pharmaceuticals (Inst); Merck (Inst); MSD (Inst); NATCO Pharma (Inst); Panacea Pharmaceuticals (Inst); Panacea Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Intas; Merck; NATCO Pharma; NATCO Pharma; PredOmix Technologies Pvt
 
Shraddha Patkar
No Relationships to Disclose
 
Shivakumar Gudi
No Relationships to Disclose
 
Anant Ramaswamy
No Relationships to Disclose
 
Sadhana Kannan
No Relationships to Disclose
 
Nitin Shetty
No Relationships to Disclose
 
Kunal Gala
No Relationships to Disclose
 
Archi Agrawal
No Relationships to Disclose
 
Mukta Ramadvar
No Relationships to Disclose
 
Prachi Patil
No Relationships to Disclose
 
Shaesta Mehta
No Relationships to Disclose
 
Rahul Krishnatry
No Relationships to Disclose
 
Satyajit Pradhan
No Relationships to Disclose
 
Lincoln Pujari
No Relationships to Disclose
 
Mayank Tripathi
No Relationships to Disclose
 
Supriya Chopra
No Relationships to Disclose
 
Dipika Chourasiya
No Relationships to Disclose
 
Sudeep Gupta
Research Funding - Amgen (Inst); AstraZeneca (Inst); Celltrion (Inst); Intas (Inst); Johnson & Johnson (Inst); Novartis (Inst); Oncostem Diagnostics (Inst); Roche (Inst); Sanofi (Inst)